New study tests tool to spot High-Risk ICU seniors
NCT ID NCT07007156
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether the NECPAL scale can help predict which older adults (75+) admitted to the ICU are more likely to die within 90 days. Researchers will follow 199 patients and compare those with a positive NECPAL result to those without. The goal is to improve care planning, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify older ICU patients who may need extra care or palliative support early on.
- What could go wrong
- This is an observational study, not a treatment trial. The scale may not accurately predict outcomes for all patients, and results may not apply to other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 199 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged 75 years or older who are admitted to an ICU
- Ages
-
75 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who meet all of the following inclusion criteria may be included in the study: * Men and women aged 75 years or older. * Admission to the ICU of the study center. * Legal capacity to provide informed consent. * Signed informed consent for study inclusion, either by the participant or their legal representative. Exclusion Criteria: Participants who meet any of the following exclusion criteria may not be included in the study: -Death within the first 24 hours of ICU admission.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CSAPG
RECRUITINGSant Pere de Ribes, Barcelona, 08800, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can High-Dose vitamin c injections ease symptoms of deficiency?
- Your smartwatch could soon warn you before you crash
- A tiny chest patch could tell doctors who's ready to leave the hospital
- Can a gut feeling save lives? ICU study tests simple predictions
- Can a simple screen get seniors moving in hospital?
- Home care for seniors: a safe alternative to the ER?